Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

1.89
Delayed Data
As of May 24
 +0.17 / +9.88%
Today’s Change
1.40
Today|||52-Week Range
18.60
-62.50%
Year-to-Date
Institutional investors control 5.87% of the outstanding shares in ROSG. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2016, these large investors purchased a net $29.1 thousand shares.
Mutual fund holders--
Individual stakeholders--
Other institutional--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/31/2017MORGAN STANLEY & CO. LLC  Bought 24.4 Thousand shares of Rosetta Genomics Ltd
3/31/2017KCG AMERICAS LLC  Bought 6.1 Thousand shares of Rosetta Genomics Ltd
3/31/2017CREATIVE PLANNING, INC.  Bought 117.00 shares of Rosetta Genomics Ltd

Top 10 Owners of Rosetta Genomics Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Morgan Stanley & Co. LLC2.62%62,239151,863+24,447+64.69%
Highlander Capital Management LLC1.38%32,92380,332-534-1.60%
Empery Asset Management LP1.35%32,17878,514-53,759-62.56%
KCG Americas LLC0.48%11,42527,877+6,127+115.65%
SEI Investments Management Corp.0.01%270659-1-0.37%
Wells Fargo Advisors Financial Ne...0.01%16740700.00%
UBS Financial Services, Inc.0.01%12530500.00%
Creative Planning, Inc.0.01%117285+117--
Citigroup Global Markets, Inc. (I...0.00%84205+1+1.20%
Morgan Stanley Smith Barney LLC (...0.00%64156-9-12.33%

Top 10 Mutual Funds Holding Rosetta Genomics Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change